Healthline: People are taking high doses of melatonin to sleep: Why experts are concerned
UC expert says taking too much melatonin could disrupt our sleep-wake cycle
According to a research letter published in the Journal of the American Medical Association, more people are taking supplemental melatonin, and at increasingly high doses. Researchers point out these findings raise safety concerns since the actual dose of melatonin supplements could be nearly 500% higher than the label indicates. In a story published by Healthline, Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine was one of the experts cited reacting to the letter.
Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine
“Melatonin is considered a dietary supplement and is not FDA approved for safety or effectiveness,” confirmed Sarah Gallucci, DO, an assistant professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine.
She added that there is an organization that confirms the claimed dosage and purity of some brands.
“Supplements that are verified by the United States Pharmacopeial convention are the most reliable,” said Gallucci. “USP verified supplements are tested to ensure that the potency and amounts match the label and that the product does not contain harmful levels of specified contaminants.”
Gallucci added that melatonin is considered “generally safe,” with few serious adverse effects.
“The most common side effects are headache, dizziness, nausea, and fatigue,” she said.
Gallucci cautioned that taking too much melatonin could disrupt our sleep-wake cycle, making it more difficult to fall asleep.
“Safe starting doses range from 2 to 5 mg,” she advised. “Melatonin does not have any addictive potential, which can be seen with some prescription sleep medications.”
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC study sheds light on copper’s role in driving kidney cancer
November 7, 2024
A new University of Cincinnati study published in the journal Cancer Discovery details how the accumulation of copper helps clear cell renal cell carcinoma grow and advance in stage.
First-generation students find a home at UC
November 7, 2024
The University of Cincinnati celebrates first-gen students, the Bearcats who are the first in their families to attend college. They bring new perspectives to student life and account for about 1 of every 5 students on campus. Nov. 8 is First Generation College Student Day, celebrated across the nation.
Research shows sex differences in cardiac outcomes for dialysis...
November 6, 2024
A published study involving University of Cincinnati experts has found significant sex differences in cardiovascular outcomes in patients with kidney failure who are on dialysis. Now the lead author is receiving an award for her work.